Clinical pharmacokinetics of camptothecin topoisomerase I inhibitors.

Abstract
In this review the clinical pharmacokinetics of camptothecin topoisomerase I inhibitors, an important new class of anticancer drugs, is discussed. Two prototypes, topotecan and irinotecan, are...

This publication has 0 references indexed in Scilit: